© 2023 BioMarin. All rights reserved.
| Recent Price | $86.94 |
|---|---|
| 52 Week High | $117.77 |
| 52 Week Low | $70.73 |
| Average Volume (30 days) | 1.08M |
| Beta | 0.38 |
| Market Cap | $16.32B |
|---|---|
| Shares Outstanding | 187.70M |
| Float | 186.53M |
| Yield % | -- |
|---|---|
| Annual Dividend | -- |
| Payout Ratio | 131.6% |
| Quick Ratio (MRQ) | 2.9 |
|---|---|
| Current Ratio (MRQ) | 4.8 |
| LT Debt/Capital (MRQ) | 19% |
| Total Debt/Equity (MRQ) | 23% |
| Price/Earnings (TTM) | 250.20 |
|---|---|
| Price/Sales (TTM) | 8.24 |
| Price/Book (MRQ) | 3.51 |
| Price/Cash Flow (TTM) | (55.30) |
| Earnings (TTM) | $0.39 |
|---|---|
| Sales (TTM) | $3.18 |
| Book Value (MRQ) | $24.98 |
| Cash Flow (TTM) | $0.79 |
| Cash (MRQ) | $1,152,091,000.00 |
| Return on Equity (TTM) | 1.6% |
|---|---|
| Return on Assets (TTM) | 1.2% |
| Return on Investment (TTM) | 1.5% |
| Gross Margin (TTM) | 75.8% |
|---|---|
| EBIT Margin (TTM) | 3.1% |
| Profit Margin (TTM) | 0.1% |